5/01/2001 – World Health Organization – SSRI Addiction

Yesterday, in several major newspapers Lilly placed full page ads offering a
coupon for a month of free Prozac. Do you think they warned the consumer in
those ads that these free pills were addictive? Because so few doctors are
aware of this withdrawal and do not know how to withdraw patients from SSRIs,
after the month on the “free” pills the patient would have to continue to
purchase the drug until they could find my tape on how to get off Prozac
safely.

Read More

4/18/2001 – Paxil Is Approved for Anxiety Disorder?!

WASHINGTON, April 16 (Bloomberg News) — Glaxo- SmithKline P.L.C. has won the
Food and Drug Administration’s approval to market its antidepressant Paxil
for treating general anxiety disorder, a new use for the drug.

That makes Paxil the first drug in its class to be approved for the
condition, which affects about 10 million Americans and involves excessive,
often debilitating worrying, the company said today.

Read More

4/09/2001 – Ghostwriting Articles for Medical Journals

April 5 (CBS) Amidst the billion-dollar competition to create the newest
blockbuster drug, there’s one thing worth more than all the ads money can
buy: a single positive mention in a respected medical journal. Doctors rely
so heavily on what’s printed in journals that a drug’s success or failure may
be directly affected.

Read More

4/9/2001 – FDA Doc Claims Fen-Phen Cover Up

April 7 (CBS) The drug company that manufactured “fen-phen,” a diet
medication linked to heart ailments, covered up problems with the drug that
emerged during Food and Drug Administration testing, a former FDA scientist
tells CBS News.

Fen-phen was removed from the market in 1997. Thousands of people who took
the drug have sued American Home Products of Madison, N.J., for health
problems they claim the drug caused.

Read More

2/24/2001 – Wall Street Journal Questions PMDD & Sarafem (Prozac)

IS SEVERE PMS, or premenstrual syndrome, a mental illness? Some
pharmaceutical companies and psychiatrists are treating it as one. In new
television ads, drug maker Eli Lilly is promoting the drug Sarafem to treat
the
problem, now dubbed Premenstrual Dysphoric Disorder (PMDD). But the
pink and purple pills aren’t a new drug — they are simply repackaged
Prozac,
the popular antidepressant.

Read More